✦ LIBER ✦

Predictive Genetic Screening and Clinical Findings in Multiple Endocrine Neoplasia Type I Families

✍ Scribed by Ina Kopp; Detlef Bartsch; Anja Wild; Thomas Schilling; Christoph Nies; Anders Bergenfelz; Harald Rieder; Babette Simon; Matthias Rothmund

Publisher: Springer
Year: 2001
Tongue: English
Weight: 164 KB
Volume: 25
Category: Article
ISSN: 0364-2313
DOI: 10.1007/s002680020170

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Presymptomatic genetic screening in fami

Presymptomatic genetic screening in families with multiple endocrine neoplasia type 2

✍ A. Frilling; W. Höppner; C. Eng; L. Mulligan; F. Raue; C. E. Broelsch 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 474 KB

Medullary thyroid carcinoma occurs sporadically or as a part of the inherited cancer syndrome multiple endocrine neoplasia (MEN) type 2. The MEN 2 gene has been identified as the RET proto-oncogene on chromosome 10. In MEN 2A, RET mutations are detectable in one of five cysteine codons within exons

Temporal bone findings in multiple endoc

Temporal bone findings in multiple endocrine neoplasia type 2B

✍ H. Fukaya; C. Suzuki; H. Yasuta; I. Ohtani 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 202 KB

Multiple endocrine neoplasia type 1 (MEN

Multiple endocrine neoplasia type 1 (MEN1) in two Asian families

✍ B. T. Teh; S. I. Hii; R. David; V. Parameswaran; S. Grimmond; M. K. Walters; T. 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 453 KB

Multiple endocrine neoplasia type 1 (MEN1), an autosomal dominant disease characterized by neoplasia of the parathyroid glands, anterior pituitary and endocrine pancreas, is rarely reported in Asian populations. The MEN1 gene, mapped to chromosome 11q13 but yet to be cloned, has been found to be hom

Genetic events in tumour initiation and

Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2

✍ Dr. Lois M. Mulligan; Emily Gardner; Barbara A. Smith; Chris G. P. Mathew; Bruce 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 928 KB

## Abstract Multiple endocrine neoplasia type 2 (MEN 2) is a familial cancer syndrome arising from mutation at a locus or loci in chromosome region 10p11.2‐q11.2. The disease is characterized by medullary thyroid carcinoma (MTC) and pheochromocytoma (Pheo). To assess the genetic events in tumour in

Genetic analysis of RET, GFRα1 and GDNF

Genetic analysis of RET, GFRα1 and GDNF genes in Spanish families with multiple endocrine neoplasia type 2A

✍ Laura Gil; Marta Azañedo; Marina Pollán; Eva Cristobal; Begoña Arribas; Luis Gar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 112 KB 👁 1 views

## Abstract Multiple endocrine neoplasia type 2A (MEN 2A) is associated with specific germline missense mutations in the __RET__ proto‐oncogene. This locus encodes a receptor tyrosine kinase whose activation requires the formation of a multimeric receptor complex including GDNF as a ligand and GFRα

Findings and long-term results of parath

Findings and long-term results of parathyroid surgery in multiple endocrine neoplasia type 1

✍ Per Hellman; Britt Skogseid; Claes Juhlin; Göran Åkerström; Jonas Rastad 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 688 KB